Having demonstrated that heterozygous Usp18 loss does not harm healthy hematopoietic cells, we next tested the effect of heterozygous Usp18 depletion in two well established murine leukemia models since ICD induction by chemotherapy has been shown to effectively kill leukemia cells21. This evidence concerns the gene USP18 and leukemia.